CIK 0001815442
- Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812992166
- Phone
- +1 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- 4 Planned sale Chief Operating Officer sold 22,240 shares at an average $85.43 ($1,900,048)
- 4 Planned sale Chief Operating Officer sold 115,977 shares at an average $78.02 ($9,048,290)
- 4 Planned sale Director sold 2,500 shares at an average $79.15 ($197,877)
- 4 Planned sale Chief Operating Officer sold 25,758 shares at an average $83.30 ($2,145,673)
- 4 Grant or award Chief Legal Officer acquired 4,125 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 5,958 shares at an average $86.54 ($515,594)
- 4 Grant or award Chief Business Officer acquired 9,225 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 10,508 shares at an average $87.24 ($916,669)
- 4 Open-market sale Chief Financial Officer sold 12,471 shares at an average $87.50 ($1,091,231)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 81,866 shares at $90.13 ($7,378,583)
- 4 Planned sale Chief Executive Officer sold 30,000 shares at an average $90.26 ($2,707,813)
- 4 Planned sale Director sold 2,500 shares at an average $87.31 ($218,270)
- 4 Planned sale Director sold 5,500 shares at an average $67.91 ($373,521)
- 4 Exercise or conversion Chief Executive Officer acquired 3,118 shares (option exercise)
- 4 Planned sale Chief Executive Officer sold 30,000 shares at an average $78.06 ($2,341,939)
- 4 Exercise or conversion Chief Executive Officer acquired 2,595 shares (option exercise)
- 4 Planned sale Director sold 27,563 shares at an average $82.16 ($2,264,480)
- 4 Open-market sale Director sold 236,588 shares at an average $91.72 ($21,699,044)
- 4 Open-market buy Director bought 2,005,813 shares at $86.00 ($172,499,918)
Page 3 of 15 · 296 filings